SLC16A1 and breast cancer: The aim of this study was to evaluate the expression of MCT1, MCT4, CD147, GLUT1 and CAIX in locally advanced BC submitted to NAC and their relationship with pCR, DFS, disease-specific survival (DSS) and OS.